Scholarly article on 9-fluoren 52670-23-2 from Journal of the American Chemical Society p. 2652 - 2654

DOI: 10.1021/ja00815a076

Source and publish data:

Journal of the American Chemical Society p. 2652 - 2654 (1974)

Update date:2022-08-04

Topics:

Authors:

Iwamura,H.

Yoshimura,K.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja00815a076

Full text of DOI:10.1021/ja00815a076

Products guided by the article

Product name:9-<2-(1-Methylcarbonylaethyl)phenyl>fluoren

Cas No:52670-23-2

R&D Labs maybe for 52670-23-2

Shanghai Balmxy Pharmaceutical Co., Ltd

Contact:0086-21-24206007

Address:Room 402, 15#, No. 909 wangyue Road, shanghai, P. R. China
Beijing Apis Biotechnology Co., Ltd.

Contact:86-010-67856775-8551

Address:NO.4PUHUANGYU ROAD,FENTAI DISTRICT, BEIJING, CHINA
Xinjiang Zhongtai Chemical Co., Ltd.

Contact:+86-991-8788172

Address:NO.78 XISHAN RD.URUMQI，CHINA
Zhengzhou HQ Material Co.,Ltd

Contact:+86-371-67759225

Address:No.32, Jinsuo Road, High-tech Zone
shijiazhuang baisheng chem co.; ltd

Contact:86-0311-80790826

Address:shijiazhuang hebei

Relevant to this article

Doi:10.1021/jo01090a015
(1959)
Doi:10.1002/hlca.19750580840
(1975)
Quantitative activity-activity relationship (QAAR) driven design to develop hydroxamate derivatives of pentanoic acids as selective HDAC8 inhibitors: synthesis, biological evaluation and binding mode of interaction studies

Doi:10.1039/d1nj02636d
(2021)
New 2,4-Diamino-5-(2′,5′-substituted benzyl)pyrimidines as Potential Drugs against Opportunistic Infections of AIDS and Other Immune Disorders. Synthesis and Species-Dependent Antifolate Activity

Doi:10.1021/jm030438k
(2004)
Essential oils and their constituents. XXXIV. Isolation of khusenic acid and isohusenic acid from oil of vetiver and some observations concerning their structures.

Doi:10.1002/jps.2600561017
(1967)
Heteroaromatic annulation of 2-methyl/2-cyanomethylbenzimidazole dianions with α-oxoketene dithioacetals: A highly regioselective synthetic protocol for 1,2-and 2,3-substituted/annulated pyrido[1,2-a]benzimidazoles

Doi:10.1021/jo026786w
(2003)

Article Doi

DOI: 10.1021/ja00815a076